Información del artículo
Bibliografía
Estadísticas
Bibliografía
[1]
Saunders JH, Oliver RJ, Higson DL..
Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice..
Br Med J, 292 (1986), pp. 665-8
[2]
Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF..
Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis: a prospective observational cohort study..
Arch Intern Med, 156 (1996), pp. 1530-6
[3]
Singh G, Triadafilopoulos G..
Epidemiology of NSAID induced gastrointestinal complications..
J Rheumathol, 26(Supl56) (1999), pp. 18-24
[4]
Sadowski DC..
Drug interactions with antiacids. Mechanisms and clinical significance..
Drug Saf, 1 (1994), pp. 395-407
[5]
Van Groenendael JH, Markuse HM, Dijkmans BA, Breedveld FC..
The effect of ranitidine on NSAID related dyspeptis symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis..
Clin Rheumatol, 15 (1996), pp. 450-6
[6]
French PC, Darekar BS, Mills JG, Wood JR..
Ranitidine in the prevention of non-steroidal anti-inflammatory drug-associated gastric and duodenal ulceration in arthritic patients..
Eur J Gastroenterol Hepatol, 6 (1994), pp. 1141-7
[7]
Taha AS, Hudson N, Hawley CJ, Swannell AJ, Trye PN, Cottrell J et al..
Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs..
N Engl J Med, 334 (1996), pp. 1435-9
[8]
Graham DY, Agrawal NW, Roth SH..
Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial..
Lancet, 2 (1988), pp. 1277-80
[9]
Graham DY, White RH, Moreland LW, Schubert TT, Katz R, Jaszewski R et al..
Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSIDs..
Ann Intern Med, 119 (1993), pp. 257-62
[10]
Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB et al..
Misoprostol dosage in the prevention of nonsteroidal antiinflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens..
Ann Intern Med, 123 (1995), pp. 344-50
[11]
Elliot SL, Yeomans ND, Buchanan RR.C, Smallwood RA..
Efficacy of 12 months. Misoprostol as prophylaxis agaisnt NSAID-induced gastric ulcers..
Scand J Rheumatol, 23 (1994), pp. 171-6
[12]
Agrawal NM, Roth S, Graham DY, White RH, Germain B, Brown JA et al..
Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer: a randomized, controlled trial..
Ann Intern Med, 115 (1991), pp. 195-200
[13]
Rodríguez de la Serna A, Díaz Rubio M, and Spanish Study Group on NSAID-induced Gastropathy Prevention..
Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenterology..
J Rheumatol, 21 (1994), pp. 927-33
[14]
Yeomans MD, Tulassay ZT, Juhasz L, Racz I, Howard JM, Van Rensburg CJ et al..
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflamatory drugs..
N Engl J Med, 338 (1998), pp. 719-26
[15]
Hawkey CJ, Karrasch JA, Szcepanski L, Walker DG, Barkun A, Swannell AJ et al..
Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs..
N Engl J Med, 338 (1998), pp. 727-34
[16]
Hawkey CJ, Tulassay Z, Szczepanski L, Van Rensburg CJ, Filipowicz-Sosnowka A, Lanas A et al..
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter eradication for lesion prevention..
Lancet, 352 (1998), pp. 1016-21